Related Experiment Video
Updated: May 24, 2025

Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
A strategic framework for managing gestational diabetes in Mexico
Luis Alberto Martinez-Juarez1,2, Héctor Gallardo-Rincón3, Rodrigo Saucedo-Martínez4
1Johns Hopkins Center for Humanitarian Health, 615 N. Wolfe Street, Baltimore, MD, 21205, USA.
Gestational Diabetes (GDM) in Mexico is underdiagnosed in 10-14% of pregnancies, leading to severe health risks. Policy action is urgently needed to improve screening, digital health, and patient education for better outcomes.
Area of Science:
- Public Health
- Maternal Health
- Health Policy
Background:
- Gestational Diabetes (GDM) affects 10-14% of pregnancies in Mexico.
- Current detection rates are critically low at approximately 5.1%.
- Underdiagnosis leads to significant health risks for mothers and infants and indicates systemic healthcare failures.
Purpose of the Study:
- To highlight the critical gap in GDM detection and management in Mexico.
- To identify contributing factors such as insufficient screening and fragmented digital health solutions.
- To advocate for policy changes to improve GDM surveillance and care.
Main Methods:
- Analysis of GDM prevalence and detection rates in Mexico.
- Identification of systemic issues in healthcare access and management.
- Review of current healthcare policies regarding GDM.
Main Results:
- A significant disparity exists between GDM prevalence and diagnosed cases.
- Uneven access to care, particularly in rural areas, contributes to underdiagnosis.
- Lack of integrated digital health solutions hinders consistent GDM management.
Conclusions:
- Urgent, coordinated policy action is required to standardize GDM screening.
- Bolstering digital health infrastructure is essential for surveillance and management.
- Public health campaigns for GDM awareness and education are crucial for early intervention and improved maternal and child health outcomes.
Related Concept Videos
Diabetes Mellitus: Type 2 and Gestational
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Hypoglycemia and Glucagon
Oral Hypoglycemic Agents: Biguanides and Glitazones

